Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2396942
Max Phase: Preclinical
Molecular Formula: C13H17ClN6O
Molecular Weight: 272.31
Molecule Type: Small molecule
Associated Items:
ID: ALA2396942
Max Phase: Preclinical
Molecular Formula: C13H17ClN6O
Molecular Weight: 272.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)N=C(N)N=C(N)N1c1cccc(OCC#N)c1.Cl
Standard InChI: InChI=1S/C13H16N6O.ClH/c1-13(2)18-11(15)17-12(16)19(13)9-4-3-5-10(8-9)20-7-6-14;/h3-5,8H,7H2,1-2H3,(H4,15,16,17,18);1H
Standard InChI Key: SXNPGOIGGYMOGD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 272.31 | Molecular Weight (Monoisotopic): 272.1386 | AlogP: 0.77 | #Rotatable Bonds: 3 |
Polar Surface Area: 113.02 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.15 | CX LogP: 0.48 | CX LogD: -0.34 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.84 | Np Likeness Score: -1.12 |
1. Simister PC, Luccarelli J, Thompson S, Appella DH, Feller SM, Hamilton AD.. (2013) Novel inhibitors of a Grb2 SH3C domain interaction identified by a virtual screen., 21 (14): [PMID:23182216] [10.1016/j.bmc.2012.10.023] |
Source(1):